Rock journalist Mitch Lafon conducted an interview with drummer Mike Mangini of progressive metal giants DREAM THEATER before the band's March 21 concert in Montreal, Quebec, Canada. You can now watch the chat below.DREAM THEATER's latest, self-titled album (available for purchase here) sold around 34,000 copies in the United States in its first week of release to debut at position No. 7 on The Billboard 200 chart. The CD arrived in stores on September 24, 2013 via Roadrunner. DREAM THEATER's "Along For The Ride" tour picked up on March 20 in Toronto, Ontario, Canada following the band's European tour and then continues through the end of April where it will eventually wrap up in Guadalajara, Mexico on April 26. DREAM THEATER's spirit of adventure and fearless musical virtuosity continues to reap dividends for the progressive metal titans who recently earned their second Grammy nomination, this time for "Best Metal Performance" for their single "The Enemy Inside" from their current self-titled album. The band — John Petrucci (guitar), John Myung (bass), James LaBrie (vocals), Jordan Rudess (keyboards & continuum) and Mike Mangini (drums) — received its first-ever Grammy nomination in 2012 for "On The Backs Of Angels" (from their "A Dramatic Turn Of Events" album) in the "Best Hard Rock/Metal Performance" category.
To comment on a BLABBERMOUTH.NET story or review, you must be logged in to an active personal account on Facebook. Once you're logged in, you will be able to comment. User comments or postings do not reflect the viewpoint of BLABBERMOUTH.NET and BLABBERMOUTH.NET does not endorse, or guarantee the accuracy of, any user comment. BLABBERMOUTH.NET reserves the right to delete postings that may be considered offensive, illegal or inappropriate and to block users that violate the site's Terms Of Service. To report any abusive, obscene, defamatory, racist, homophobic or threatening comments, or anything that may violate any applicable laws, please send an e-mail to blabbermouthinbox(@)gmail.com with pertinent details.